Written by Katreen David
While many sectors suspect that artificial intelligence (AI) may one day replace human intelligence, the life sciences industry will soon embrace it as a force for good. AI has the power to improve the infrastructure of the clinical trial supply chain, boosting the quality of healthcare.
“On the surface, AI may seem like just a tool, but it’s actually a game-changer for clinical trials and pharmaceutical logistics,” says Aparna Seksaria, a Life Sciences Solutions lead at SAP America.
As the life sciences sector undergoes digital transformation, Seksaria interweaves her influence throughout the AI ladder, making her a catalyst for change. Her work proves that wonderful things can happen when AI and human ingenuity join forces.
Transforming Clinical Trials with AI
The global pharmaceutical market has seen a substantial uptick in recent years, with AI-driven innovations leading the pack. The life sciences sector in the United States grew substantially due to advancements in AI applications across drug discovery, development, and manufacturing. Seksaria’s initiatives are making sure that pharmaceutical companies can conduct trials more efficiently and accurately, addressing one of the most critical pain points in drug development.
“Efficiency and scalability are paramount in clinical trials,” Seksaria notes. “Our AI solutions at SAP streamline operations and significantly reduce supply chain costs while improving accuracy.”
This perspective reflects the broader industry trend of utilizing AI to enhance operational efficiency. The integration of AI has enabled companies to predict trial outcomes, optimize resource allocation, and monitor real-time data more effectively than ever before.
The Digital Transformation of Pharma
The digital transformation in the pharmaceutical industry is more than just a passing trend; it is here to stay. Cloud-based solutions have become integral to this shift, offering scalable and flexible platforms for managing vast amounts of data generated during clinical trials.
Seksaria’s leadership in this area has been instrumental. Through her alignment of pharmaceutical business processes with cloud technologies, she has devised systems that are as efficient as they are adaptable to the rapidly changing field of drug development.
“Preparing pharma for the digital future is a continuous process,” Seksaria explains. “We must anticipate technological advancements and integrate them seamlessly into existing workflows.” This proactive methodology has further solidified SAP as a leader in the field, providing pharmaceutical companies with the tools they need to remain competitive.
Driving Clinical Process Innovation
Furthermore, Seksaria plays a key role in facilitating the system and process design of internal and external manufacturing processes while maintaining regulatory compliance, which is vital for certifying product quality and safety.
One of Seksaria’s most notable projects was the initiative to develop a solution for exchanging information between clinical trial companies and contract manufacturing organizations (CMOs).
“In 2023, SAP needed a dedicated solution for this purpose,” Seksaria shares. “I led this project, engaging with customers to understand their requirements and evaluating our internal products. We enhanced business netwrok product to build the necessary clinical trial processes, avoiding the need to start from scratch.”
This effort culminated in a fully developed product set to launch in November 2024, demonstrating Seksaria’s ability to drive innovation and deliver impactful solutions.
The Tomorrows of Pharma: Supercharged with AI
Seksaria’s forward-looking techniques are essential for maintaining a competitive edge in the elastic pharmaceutical landscape. Companies that fail to adopt and integrate AI risk falling behind, while those that embrace these technologies will lead the way in innovation and efficiency.
As the life sciences sector navigates the complexities of the digital age, leaders like Seksaria are not just adapting to change—they are driving it. Her work epitomizes the intersection of technology and healthcare. With this, Aparna Seksaria offers a glimpse into a future where AI and human proficiency merge to deliver unprecedented advancements in medical science.
